Ignite Creation Date:
2025-12-24 @ 11:11 PM
Ignite Modification Date:
2026-01-01 @ 11:41 PM
Study NCT ID:
NCT07038369
Status:
RECRUITING
Last Update Posted:
2025-12-09
First Post:
2025-06-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations
Sponsor:
Atavistik Bio, Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-07-29
Start Date Type:
ACTUAL
Primary Completion Date:
2028-08-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-01-31
Completion Date Type:
ESTIMATED
First Submit Date:
2025-06-18
First Submit QC Date:
None
Study First Post Date:
2025-06-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-08
Last Update Post Date:
2025-12-09
Last Update Post Date Type:
ESTIMATED